Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 284-288 , February 2010

Enhanced ghrelin secretion in the cephalic phase of food ingestion in women with bulimia nervosa

Received 21 May 2009 ,Revised 29 June 2009 ,Accepted 1 July 2009.

References 

  1. Arosio M, Ronchi CL, Beck-Peccoz P, Gebbia C, Ciavoli C, Cappiello V, et al. Effects of modified sham feeding on ghrelin levels in healthy human subjects. J. Clin. Endocrinol. Metab. 2004;89:5101–5104
  2. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 2001;120:337–345
  3. Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut. 2005;54:18–24
  4. de Zwaan M, Biener D, Bach M, Wiesnagrotzki S, Stacher G. Pain sensitivity, alexithymia, and depression in patients with eating disorders: are they related?. J. Psychosom. Res. 1996;41:65–70
  5. Dixon J. BMDP Statistical Software. Berkley: University of California Press; 1985;
  6. Faris PL, Kim SW, Meller WH, Goodale RL, Oakman SA, Hofbauer RD, et al. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. Lancet. 2000;355:792–797
  7. Feldman M, Richardson CT. Role of thought, sight, smell, and taste of food in the cephalic phase of gastric acid secretion in humans. Gastroenterology. 1986;90:428–433
  8. First, M.B., Gibbon, M., Spitzer, R.L., Williams, J.B.W., 1996. Structured Clinical Interview for Axis I DSM-IV Disorders-Non-Patient Ed. (SCID-I/NP, Version 2.0). New York State Psychiatric Institute, Biometrics Research Department, New York.
  9. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B., 1995. Structured Clinical Interview for DSM-IV Axis I Disorders – Patient Ed. (SCID-I/P, Version 2). New York State Psychiatric Institute, Biometrics Research Department, New York.
  10. Keel PK, Wolf BE, Liddle RA, De Young KP, Jimerson DC. Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa. Arch. Gen. Psychiatry. 2007;64:1058–1066
  11. Kojima S, Nakahara T, Nagai N, Muranaga T, Tanaka M, Yasuhara D, et al. Altered ghrelin and peptide YY responses to meals in bulimia nervosa. Clin. Endocrinol. 2005;62:74–78
  12. Monteleone P, Martiadis V, Rigamonti AE, Fabrazzo M, Giordani C, Muller EE, et al. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biol. Psychiatry. 2005;57:926–931
  13. Monteleone P, Castaldo E, Maj M. Neuroendocrine dysregulation of food intake in eating disorders. Regul. Pept. 2008;149:39–50
  14. Monteleone P, Serritella C, Martiadis V, Maj M. Deranged secretion of ghrelin and obestatin in the cephalic phase of vagal stimulation in women with anorexia nervosa. Biol. Psychiatry. 2008;64:1005–1008
  15. Murialdo G, Casu M, Falchero M, Brugnolo A, Patrone V, Cerro PF, et al. Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels. J. Endocrinol. Invest. 2007;30:356–362
  16. Rissanen A, Naukkarinen H, Virkkunen M, Rawlings RR, Linnoila M. Fluoxetine normalizes increased cardiac vagal tone in bulimia nervosa. J. Clin. Psychopharmacol. 1998;18:26–32
  17. Robertson MD, Jackson KG, Williams CM, Fielding BA, Frayn KN. Prolonged effects of modified sham feeding on energy substrate mobilization. Am. J. Clin. Nutr. 2001;73:111–117
  18. Simonian HP, Kresg eKM, Boden GH, Parkman HP. Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release. Neurogastroenterol. Motil. 2005;17:348–354
  19. Waters A, Hill A, Waller G. Bulimics’ responses to food cravings: is binge-eating a product of hunger or emotional state?. Behav. Res. Ther. 2001;39:877–886
  20. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science. 2005;310:996–999

PII: S0306-4530(09)00212-1

doi: 10.1016/j.psyneuen.2009.07.001

Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 284-288 , February 2010

Article Tools

* Image Usage & Resolution